These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 38791032)

  • 1. Plasma Biomarkers for Hypertension-Mediated Organ Damage Detection: A Narrative Review.
    Liu X; Yang M; Lip GYH; McDowell G
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38791032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Biomarkers to Detect Target Organ Damage in Acute Hypertension.
    Boone S; Kuo D
    Curr Hypertens Rep; 2018 Mar; 20(3):21. PubMed ID: 29556795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel biomarkers in patients with uncontrolled hypertension with and without kidney damage.
    Brobak KM; Halvorsen LV; Aass HCD; Søraas CL; Aune A; Olsen E; Bergland OU; Rognstad S; Blom KB; Birkeland JAK; Høieggen A; Larstorp ACK; Solbu MD
    Blood Press; 2024 Dec; 33(1):2323980. PubMed ID: 38606688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertensive Mediated Organ Damage and Hypertension Management. How to Assess Beneficial Effects of Antihypertensive Treatments?
    Piskorz D
    High Blood Press Cardiovasc Prev; 2020 Feb; 27(1):9-17. PubMed ID: 31975151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma N-Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats.
    Bijsmans ES; Jepson RE; Wheeler C; Syme HM; Elliott J
    J Vet Intern Med; 2017 May; 31(3):650-660. PubMed ID: 28387019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of hypertension-mediated organ damage in children and adolescents with hypertension.
    Pac M; Obrycki Ł; Koziej J; Skoczyński K; Starnawska-Bojsza A; Litwin M
    Blood Press; 2023 Dec; 32(1):2212085. PubMed ID: 37259507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease.
    Swinford RD; Portman RJ
    Adv Chronic Kidney Dis; 2004 Apr; 11(2):143-61. PubMed ID: 15216486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent insights in the development of organ damage caused by hypertension.
    Persu A; De Plaen JF
    Acta Cardiol; 2004 Aug; 59(4):369-81. PubMed ID: 15368798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Cardiotrophin-1 as a Marker of Hypertension and Diabetes-Induced Target Organ Damage and Cardiovascular Risk.
    Gamella-Pozuelo L; Fuentes-Calvo I; Gómez-Marcos MA; Recio-Rodriguez JI; Agudo-Conde C; Fernández-Martín JL; Cannata-Andía JB; López-Novoa JM; García-Ortiz L; Martínez-Salgado C
    Medicine (Baltimore); 2015 Jul; 94(30):e1218. PubMed ID: 26222851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptides and neprilysin inhibition in hypertension and hypertensive organ damage.
    Kato J
    Peptides; 2020 Oct; 132():170352. PubMed ID: 32610060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: A narrative review.
    Miceli F; Presta V; Citoni B; Canichella F; Figliuzzi I; Ferrucci A; Volpe M; Tocci G
    J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1863-1871. PubMed ID: 31693279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Biomarkers in the Evaluation and Treatment of Hypertensive Patients.
    Currie G; Delles C
    Curr Hypertens Rep; 2016 Jul; 18(7):54. PubMed ID: 27221728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression.
    Cushman WC
    J Clin Hypertens (Greenwich); 2003; 5(3 Suppl 2):14-22. PubMed ID: 12826766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in hypertension and their relationship with myocardial target-organ damage.
    Xue Y; Iqbal N; Chan J; Maisel A
    Curr Hypertens Rep; 2014 Dec; 16(12):502. PubMed ID: 25304110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease.
    Houston MC
    Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):165-83. PubMed ID: 20400494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End organ damage in hypertension.
    Schmieder RE
    Dtsch Arztebl Int; 2010 Dec; 107(49):866-73. PubMed ID: 21191547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.